Progress Against RAS-Driven Cancers Lauded at RAS Symposium, With More Candidate Treatments on Horizon
November 20, 2024
November 20, 2024
FREDERICK, Maryland, Nov. 20 (TNSres) -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:
By Mary Ellen Hackett
Researchers from around the world met in October to mark progress their field has made in developing drugs to treat cancers driven by the RAS oncogene, and to map out even more ways they can help cancer patients.
"This is a great story about tackling an intractable disease that was said t . . .
By Mary Ellen Hackett
Researchers from around the world met in October to mark progress their field has made in developing drugs to treat cancers driven by the RAS oncogene, and to map out even more ways they can help cancer patients.
"This is a great story about tackling an intractable disease that was said t . . .